Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-04

Clinical Trial Update: Transcutaneous Vagus Nerve Stimulation on Fibromyalgia- Double-blind, Sham-controlled Randomized Clinical Trial [NA]

View source ↗

Summary

An update on a double-blind, sham-controlled randomized trial evaluating transcutaneous vagus nerve stimulation for fibromyalgia, which is currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Transcutaneous Vagus Nerve Stimulation

Snippet

Sponsor: National and Kapodistrian University of Athens | Conditions: Transcutaneous Vagus Nerve Stimulation on Fibromyalgia | NA | Status: RECRUITING